Narayana Hrudayalaya

Narayana Hrudayalaya

1,789.40
+36.40
(2.08%)
hide
Key Fundamentals
Add Ratio
Market Cap
35,824.40 Cr
EPS
38.90
PE Ratio
45.28
Dividend Yield
0.26 %
52 Week High
2,370.20
52 Week Low
1,185.00
PB Ratio
9.87
Debt to Equity
0.62
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+33.33 %
+33.33 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Narayana Hrudayalaya's quarterly results showed mixed performance across operations. India operations demonstrated improvement with expanded EBITDA margins driven by better payor mix, higher value procedures, and price increases. The company's Average Length of Stay decreased from 4.5 to 4.3 days. Cayman Islands operations generated $45 million in revenue but faced challenges with EBITDA declining by INR 20-25 crores sequentially due to margin dilution from the new Integrated Care business. The new hospital ramp-up continues with all services now activated. Government schemes represented 19% of the patient mix, while Bangladesh revenue dropped 50% year-over-year. The company's insurance business maintained flat Gross Written Premium covering 6,000 policyholders. Oncology operations are growing with management targeting 20-25% of total revenue within five years. Narayana Hrudayalaya announced expansion plans including new hospitals in Bangalore, Kolkata, and Raipur by FY27-28, supported by INR 3,000 crores in capex. Digital transformation initiatives include paperless hospitals and improved ICU systems. The Integrated Care model is expected to reach breakeven in 1-2 years, while new insurance and clinic businesses remain in investment phase with initial losses.
positive
Narayana Hrudayalaya Limited submitted a revised investor presentation for the quarter ended June 30, 2025. The healthcare company reported consolidated operating revenues of ₹15,073 million in Q1 FY26, representing a 15.4% year-over-year increase and 2.2% quarter-over-quarter growth. The company achieved consolidated EBITDA of ₹3,607 million with a margin of 23.9% and consolidated profit after tax of ₹1,961 million with a margin of 13.0%. The company operates 40 healthcare facilities with 5,563 operational beds across India and Cayman Islands, including 18 owned/operated hospitals, 2 heart centers, and 18 clinics. Net debt to equity ratio stands at 0.09 with total borrowings less cash and investments of ₹3,430 million as of June 30, 2025. The company has expansion plans targeting over 7,600 bed capacity with multiple projects in progress across Bangalore, Kolkata, and Raipur.
positive
Narayana Health achieved double-digit growth in Q1 FY26 while maintaining strong business momentum. The healthcare company is implementing strategic capital expenditure initiatives and pursuing deep technology-led transformation. The company is focusing on scalable healthcare expansion with an emphasis on ESG-driven operations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,662.00
#1 1,07,112.40
68.02
#1 21,994.30
14.76
#1 1,505
39.78
36.12
1,139.70
1,03,951.50
86.63
7,184.10
#1 28.68
1,076
30.34
26.68
1,053.90
74,016.10
80.07
7,849.70
13.25
809
#1 53.33
60.13
1,789.40
#4 35,824.40
#1 45.28
#4 5,575.00
#10 12.29
#4 790
#7 -2.38
46.96
1,366.30
35,716.90
62.59
3,771.40
12.59
481
49.58
46.77
672.55
33,452.50
93.51
4,286.70
15.12
337
-98.18
58.66
722.20
27,623.60
75.04
3,067.00
21.98
415
-10.71
31.32
1,328.90
13,753.10
53.44
1,566.90
17.46
244
35.52
27.90
1,486.00
9,728.70
50.49
1,290.20
17.77
194
-1.57
52.43
658.70
9,080.40
245.06
2,257.70
17.03
49
-55.88
44.22
Growth Rate
Revenue Growth
12.29 %
Net Income Growth
0.48 %
Cash Flow Change
-7.58 %
ROE
-20.08 %
ROCE
-17.99 %
EBITDA Margin (Avg.)
-0.28 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,273
1,331
1,424
1,353
1,503
1,532
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
955
1,004
1,092
1,028
1,126
1,171
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
377
361
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
23 %
24 %
22 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
61
65
70
83
84
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
41
45
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
225
231
232
219
254
232
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
34
30
33
26
57
35
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
197
197
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50
9.71
9.68

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
4,266
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
2,550
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
86
Investments
0
87
96
9
17
86
120
132
252
844
1,084
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
1,829
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
1,193
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
2,444
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
3,628
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
3,423
Share Capital
200
204
204
204
204
204
204
204
204
204
204

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
205
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
-1,325
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
986
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489
544

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
9.66 %
10.46 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
8.52 %
8.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
11.47 %
11.18 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
6.50 %
6.42 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787
2,05,639

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 4.5
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.24 0.26

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Aug 2022 DIVIDEND Dividend
₹ 1.00 /share
22 Aug 2022 659.80 705.15
07 Jul 2023 DIVIDEND Dividend
₹ 2.50 /share
07 Jul 2023 767.85 1,012.95
02 Aug 2024 DIVIDEND Dividend
₹ 4.00 /share
02 Aug 2024 1,255.10 1,252.75
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Aug 2024 1,255.10 1,265.50
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2024 1,236.20 1,222.55
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 1,372.70 1,329.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 1,790.70 1,724.30
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 1,991.45 1,916.05
01 Aug 2025 DIVIDEND Dividend
₹ 4.50 /share
01 Aug 2025 1,724.30 1,916.05
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 1,724.30 1,753.75

Announcements

Closure of Trading Window9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement Under Regulation 30 - AcquisitionSep 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Letter To Shareholders- Weblink Of 25Th AGM Notice And Annual Report For FY 2024-25Aug 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Regulation 53 (1) Annual Report.Aug 07, 2025
Reg. 34 (1) Annual Report.Aug 07, 2025
Notice Of The 25Th Annual General Meeting (AGM) Of The Company For F.Y. 2024-25Aug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Recommendation By The Board For The Issuance Of Non-Convertible Securities.Aug 01, 2025
Board Meeting Outcome for Outcome Of The Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30 2025 Aug 01, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025 Aug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2025
Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025 And Fund Raising.Jul 28, 2025
Communication To Shareholders - Intimation On Tax Deduction On DividendJul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 27, 2025
Closure of Trading WindowJun 27, 2025
Rumour verification - Regulation 30(11)Jun 26, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Clarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.May 27, 2025
Clarification sought from Narayana Hrudayalaya LtdMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
Shareholders MeetingMay 23, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Mirae Asset Small Cap Fund Direct-Growth
1.92%
87000
0.50%
0.10%
Sundaram Multi-Factor Fund Direct-Growth
1.35%
66430
1.35%
1.35%
Axis Small Cap Fund Direct-Growth
1.69%
-51173
-0.15%
-0.38%
Mirae Asset Multicap Fund Direct - Growth
0.99%
43001
0.11%
-0.20%
DSP Small Cap Direct Plan-Growth
0.76%
-40000
-0.10%
-0.38%
Axis Momentum Fund Direct - Growth
2.91%
-29398
-0.53%
-0.77%
Mirae Asset Flexi Cap Fund Direct - Growth
1.47%
15000
-0.05%
-0.26%
Shriram Multi Asset Allocation Fund Direct - Growth
0.84%
-10132
-1.46%
-1.57%
Shriram Flexi Cap Fund Direct - Growth
1.03%
-8700
-1.28%
-1.52%
Navi Large & Midcap Fund Direct-Growth
0.68%
8500
0.47%
0.45%
Taurus Flexi Cap Fund Direct - Growth
1.14%
4550
0.16%
0.06%
Unifi Flexi Cap Fund Direct-Growth
2.00%
4001
0.29%
-0.23%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.63%
3211
0.63%
0.63%
Shriram ELSS Tax Saver Fund Direct - Growth
1.04%
-3100
-1.26%
-1.49%
UTI Multi Asset Allocation Fund Direct-Growth
0.18%
2500
-0.01%
0.18%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.63%
2468
-0.04%
-0.10%
Quantum Ethical Fund Direct - Growth
1.19%
1680
0.27%
0.06%
Nippon India Nifty 500 Momentum 50 Index Fund Direct-Growth
1.00%
1541
-0.05%
-0.12%
Bandhan Nifty Alpha 50 Index Fund Direct-Growth
1.70%
1335
-0.05%
-0.22%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
1.00%
1221
-0.05%
-0.13%
Shriram Aggressive Hybrid Fund Direct -Growth
0.57%
-1149
-0.49%
-0.61%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.63%
1094
-0.03%
-0.09%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.63%
975
-0.03%
-0.10%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.63%
751
-0.04%
-0.10%
Kotak Nifty Alpha 50 Index Fund Direct-Growth
1.69%
742
1.69%
1.69%

Technical Indicators

RSI(14)
Neutral
46.96
ATR(14)
Volatile
46.85
STOCH(9,6)
Neutral
35.44
STOCH RSI(14)
Neutral
48.91
MACD(12,26)
Bullish
2.34
ADX(14)
Weak Trend
20.65
UO(9)
Bearish
42.08
ROC(12)
Downtrend And Accelerating
-1.82
WillR(14)
Neutral
-57.48

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years, 0 days)
Chairperson NameDEVI PRASAD SHETTY